Dexamethasone Upregulates the Expression of the Human SLC26A3 (DRA, D own- R egulated in A denoma) Transporter (an IBD Susceptibility Gene) in Intestinal Epithelial Cells and Attenuates Gut Inflammation
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae271 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Anoop Kumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Jesse Brown VA Medical Center, Research and Development, Chicago, IL, USA. Hauptthemen laut MEDLINE: Dexamethasone, Inflammatory Bowel Diseases, Intestinal Mucosa, Antiporters. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: VA Senior Research Career Scientist Award, BLRD VA, NIDDK NIH HHS.
Abstract (Originalsprache)
Background
Down-Regulated in Adenoma (DRA) plays a critical role in intestinal chloride absorption and a decrease in its expression is a key event in diarrheal disorders. Recently, DRA has emerged as an Inflammatory Bowel Disease (IBD) susceptibility gene. Therefore, the strategies to upregulate DRA expression are potentially novel approaches to not only treat IBD-associated diarrhea but also gut inflammation. In this study, the effect of dexamethasone (DEX), an anti-inflammatory corticosteroid on DRA expression was investigated.
Methods
GR (glucocorticoid receptor) overexpressed Caco-2 cells and C57BL/6/J mice and anti-αIL-10R mAb model of IBD were used. Protein expression was assessed by immunoblotting and immunofluorescence. Transcript levels were assessed by quantative-real-time polymerase chain reaction (qRT-PCR) and promoter activity was measured by luciferase assays.
Results
Our results showed that DEX significantly increased DRA mRNA and protein expression in GR overexpressing Caco-2 cells. DEX-induced upregulation of DRA was GR dependent and appeared at least in part to occur via a transcriptional mechanism, as promoter activity of the DRA construct (−1183/+114 bp) was significantly increased in response to DEX. The increase in DRA mRNA was abrogated in the presence of MKP-1 inhibitor, triptolide. Administration of DEX (2 mg/kg body weight) to mice for 24 and 48 hours significantly increased the DRA expression in mouse colon. DEX treatment to mice for 7 days in the αIL-10R mAb model of colitis was able to significantly attenuate the gut inflammation and associated decrease in DRA expression.
Conclusions
We demonstrate that DEX stimulates DRA expression via transcriptional mechanisms and suggest that upregulation of DRA may contribute to both anti-inflammatory and pro-absorptive effects of DEX.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jesse Brown VA Medical Center, Research and Development, Chicago, IL, USA.
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois Chicago, Chicago, IL, USA.
- Department of Pathology, College of Medicine, University of Illinois Chicago, Chicago, IL, USA.
ORCID-Profile: Anoop Kumar
Förderung
- VA Senior Research Career Scientist Award
- BLRD VA
- NIDDK NIH HHS
- NIH/NIDDK
- Department of Veterans Affairs, Merit Review Award
- VA-BCCMA Award
- U.S. Department of Veterans Affairs
- Veterans Affairs
Zitieren
APA
Kumar, A., Husain, N., Anbazhagan, A. N., Jayawardena, D., Priyamvada, S., Singhal, M., Jain, C., Kaur, P., Guzman, G., Saksena, S., & Dudeja, P. K. (2025). Dexamethasone Upregulates the Expression of the Human SLC26A3 (DRA, D own- R egulated in A denoma) Transporter (an IBD Susceptibility Gene) in Intestinal Epithelial Cells and Attenuates Gut Inflammation. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae271
Vancouver
Kumar A, Husain N, Anbazhagan AN, Jayawardena D, Priyamvada S, Singhal M, et al. Dexamethasone Upregulates the Expression of the Human SLC26A3 (DRA, D own- R egulated in A denoma) Transporter (an IBD Susceptibility Gene) in Intestinal Epithelial Cells and Attenuates Gut Inflammation. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae271
BibTeX
@article{Kumar2025,
author = {Kumar, Anoop and Husain, Nazim and Anbazhagan, Arivarasu N and Jayawardena, Dulari and Priyamvada, Shubha and Singhal, Megha and Jain, Charu and Kaur, Prabhdeep and Guzman, Grace and Saksena, Seema and Dudeja, Pradeep K},
title = {Dexamethasone Upregulates the Expression of the Human SLC26A3 (DRA, D own- R egulated in A denoma) Transporter (an IBD Susceptibility Gene) in Intestinal Epithelial Cells and Attenuates Gut Inflammation},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae271}
}
EUVIMED